Добірка наукової літератури з теми "Prednisolone in serum"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Prednisolone in serum".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Prednisolone in serum"
Owen, LJ, S. Gillingwater, and BG Keevil. "Prednisolone measurement in human serum using liquid chromatography tandem mass spectrometry." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 42, no. 2 (March 1, 2005): 105–11. http://dx.doi.org/10.1258/0004563053492810.
Повний текст джерелаRamshanker, Nilani, Maiken Aagaard, Rikke Hjortebjerg, Thomas Schmidt Voss, Niels Møller, Jens Otto Lunde Jørgensen, Niels Jessen, et al. "Effects of Prednisolone on Serum and Tissue Fluid IGF-I Receptor Activation and Post-Receptor Signaling in Humans." Journal of Clinical Endocrinology & Metabolism 102, no. 11 (September 13, 2017): 4031–40. http://dx.doi.org/10.1210/jc.2017-00696.
Повний текст джерелаGleeson, Dermot. "Standard Treatment in Adults: Which Steroid? Or without Steroids?" Digestive Diseases 33, Suppl. 2 (2015): 75–82. http://dx.doi.org/10.1159/000440751.
Повний текст джерелаKirimi, E., O. Tuncer, M. Kösem, E. Ceylan, A. Tas, I. Tasal, R. Balahoroğlu, and H. Caksen. "The Effects of Prednisolone and Serum Malondialdehyde Levels in Puppies with Experimentally Induced Meconium Aspiration Syndrome." Journal of International Medical Research 31, no. 2 (April 2003): 113–22. http://dx.doi.org/10.1177/147323000303100207.
Повний текст джерелаMobisson, Samuel K., Peter C. Onyebuagu, Iheanyichukwu Wopara, Desmond Izunwanne, Emmanuel C. Madu, Augustine C. Emeruem, Justin B. Monye, and Agona O. Obembe. "Impact of Cannabidiol oil and prednisolone on liver enzymes, oxidative stress markers and liver histology in cadmium induced toxicity in male Wistar rats." Journal of African Association of Physiological Sciences 11, no. 1 (August 28, 2023): 36–44. http://dx.doi.org/10.4314/jaaps.v11i1.4.
Повний текст джерелаSchou, A. J., and O. D. Wolthers. "Serum Fructosamine, Total Cholesterol, and High-Density Lipoprotein in Children with Asthma during Glucocorticoid Treatment." ISRN Allergy 2011 (August 14, 2011): 1–4. http://dx.doi.org/10.5402/2011/295124.
Повний текст джерелаAlizadeh Dehnavi, Reza, Jouke T. Tamsma, and A. Edo Meinders. "The effect of prednisolone on serum sodium concentration." European Journal of Internal Medicine 17, no. 3 (May 2006): 201–3. http://dx.doi.org/10.1016/j.ejim.2005.11.018.
Повний текст джерелаRebolledo, Rolando A., Bo Liu, Mohammed Z. Akhtar, Petra J. Ottens, Jian-ning Zhang, Rutger J. Ploeg, and Henri G. D. Leuvenink. "Steroid Anti-Inflammatory Effects Did Not Improve Organ Quality in Brain-Dead Rats." BioMed Research International 2015 (2015): 1–10. http://dx.doi.org/10.1155/2015/207534.
Повний текст джерелаQaisar, Imran, Abid Ali Anjum, Abdul Rehman, and Iftikhar Ahmed. "Comparison of efficacy of single dose versus split dose prednisolone therapy in achieving remission in patients with nephrotic syndrome in children." Journal of Fatima Jinnah Medical University 15, no. 4 (April 7, 2022): 181–83. http://dx.doi.org/10.37018/ewsh7228.
Повний текст джерелаSandhu, Milap S., Elizabeth Gray, Masha Kocherginsky, Arun Jayaraman, Gordon S. Mitchell, and William Z. Rymer. "Prednisolone Pretreatment Enhances Intermittent Hypoxia-Induced Plasticity in Persons With Chronic Incomplete Spinal Cord Injury." Neurorehabilitation and Neural Repair 33, no. 11 (September 15, 2019): 911–21. http://dx.doi.org/10.1177/1545968319872992.
Повний текст джерелаДисертації з теми "Prednisolone in serum"
Mendoza, Beatriz Costa Gago. "The effect of prednisolone therapy on canine serum levels of 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase." Master's thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2020. http://hdl.handle.net/10400.5/20543.
Повний текст джерелаABSTRACT - 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase is a widely available biomarker, increasingly used in the investigation of canine pancreatitis mainly due to its low cost compared to pancreatic lipase immunoreactivity (cPLI). A previous study showed a good agreement between cPLI and DGGR lipase concentration. While the effect of corticotherapy on cPLI quantification has been studied, its influence on DGGR lipase is unknown. This study aims to evaluate the effect of prednisolone therapy in canine DGGR lipase serum levels. A prospective cohort study was conducted, including the measurement of DGGR lipase in two groups: the study group (SG) composed of dogs treated with oral prednisolone for a medical reason, at the initial dosage of 0.5-1.7 mg/kg/day for at least 3 weeks, and the control group (CG) composed of healthy untreated dogs. As an inclusion criterion, animals had basal DGGR lipase within the reference range (<80 U/L). DGGR lipase was measured at three time points (Day 0(T0), Day 7-10(T1), and Day 21-30(T2)) in both groups. The analysis was performed using a previously validated kit (Randox® DGGR lipase). Thirty-four dogs were included (17 dogs for each group, which were age and sex-matched). At T0, there was no significant difference in DGGR lipase concentrations between groups (p=0.868). Mean starting dosage of prednisolone was 0.94 (±0.85) mg/kg/day, decreasing to 0.45 (±0.05) mg/kg/day after T1. The median DGGR lipase concentration in SG at each time point (T0, T1, and T2) was: 24.74 (14.45-31.48) U/L, 36.82 (23.8-80.16) U/L and 29.52 (15.91-48.48) U/L, respectively. There was a statistically significant effect of prednisolone on DGGR lipase values (p=0.007) over T0, T1, and T2. A poor correlation was verified between the variations of DGGR lipase and the correspondent prednisolone dosage of T0-T1 and T1-T2 (rs=0.371 e rs=0.121, respectively). In CG, DGGR lipase did not significantly change over the three time points (p=0.926). This study suggests that DGGR lipase levels are affected by oral prednisolone therapy in dogs treated for a medical reason. However, as values remained below the considered significant upper limit (160 U/L), this variation does not seem to be clinically relevant.
RESUMO - O EFEITO DA PREDNISOLONA NO DOSEAMENTO DA 1,2-O-DILAURYL-RAC- -GLYCERO GLUTARIC ACID-(6′-METHYLRESORUFIN) ESTER (DGGR) LIPASE - 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase é um biomarcador recentemente disponível, que tem vindo a ser cada vez mais utilizado na exploração clínica de pancreatite em cães, sobretudo pelo seu custo acessível face à lipase pancreática específica (cPLI). Foi demonstrada uma boa concordância entre a cPLI e a DGGR lipase. Estudos prévios avaliaram a influência da corticoterapia no doseamento de cPLI. Contudo, a influência na DGGR lipase ainda não é conhecida. Este estudo visa avaliar o efeito da prednisolona nos níveis sérios de DGGR lipase em cães. Foi efetuado um estudo prospetivo de coorte, que incluiu a medição da DGGR lipase em dois grupos: o grupo de estudo (GE) constituído por cães aos quais foi administrada prednisolona por via oral com justificação médica na dose inicial de 0.5-1.7mg/kg/dia durante pelo menos 3 semanas e o grupo controlo (GC) composto por cães saudáveis sem tratamento concomitante. Como critério de inclusão consideraram-se cães com valores de DGGR lipase abaixo do valor de referência (<80 U/L). A DGGR lipase foi quantificada em três pontos temporais (Dia 0 (T0), Dia 7-10 (T1) e Dia 21-30 (T2)). A análise foi efetuada com recurso a um kit previamente validado (Randox® DGGR lipase). Foram incluídos 34 cães (17 cães em cada grupo, emparelhados relativamente ao género e idade). Em T0 não se observou diferença estatisticamente significativa entre grupos (p=0.868). A dose inicial média de prednisolona foi de 0.94 (±0.85) mg/kg/dia, tendo decrescido para 0.45 (±0.05) mg/kg/dia após T1. A concentração mediana de DGGR lipase no GE em cada ponto temporal (T0, T1 e T2) foi: 24.74 (14.45-31.48) U/L, 36.82 (23.8-80.16) U/L e 29.52 (15.91-48.48) U/L, respetivamente. Observou-se um efeito estatisticamente significativo da prednisolona nos valores de DGGR lipase ao longo de T0, T1 e T2 (p=0.007). Foi verificada uma baixa correlação entre as variações de DGGR lipase e a dose de prednisolona correspondente em T0-T1 e T1-T2 (rs=0.371 e rs=0.121, respetivamente). Em relação ao GC não se observaram diferenças estatisticamente significativas ao longo de T0, T1 e T2 (p=0.926). Sugere-se que a DGGR lipase seja afetada pela administração oral de prednisolona por justificação médica. No entanto, como os valores permanecem abaixo do limite máximo considerado (160 U/L), esta variação não aparenta ser clinicamente relevante.
N/A
Частини книг з теми "Prednisolone in serum"
Webb, G. J., and Gideon M. Hirschfield. "Autoimmune hepatitis." In Oxford Textbook of Medicine, edited by Jack Satsangi, 3119–27. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0324.
Повний текст джерелаRahman, Nurun N. "Binding of Betamethasone, Prednisolone and Theophylline to Bovine Serum Albumin: Plausible Explanations for Mode of Binding and." In Frontiers in Natural Product Chemistry, 77–88. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/978160805212710501010077.
Повний текст джерелаO’Grady, John G. "Liver transplantation." In Oxford Textbook of Medicine, edited by Jack Satsangi, 3100–3107. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0322.
Повний текст джерелаRahman, Nurun N., S. Huda, Khondaker M. Rahman, and Mohammad H. Rahman. "Binding of Betamethasone, Prednisolone and Theophylline to Bovine Serum Albumin: Plausible Explanations for Mode of Binding and Drug-drug Interactions." In Frontiers in Natural Product Chemistry, 77–88. BENTHAM SCIENCE PUBLISHERS, 2009. http://dx.doi.org/10.2174/907752704410501010077.
Повний текст джерелаТези доповідей конференцій з теми "Prednisolone in serum"
Papamanoli, A., A. Kalogeropoulos, J. Hotelling, J. Yoo, P. Grewal, W. Predun, R. Jacob, S. Rawal, L. Marcos, and H. Skopicki. "Admission Serum Ferritin Levels and Effect of Methyl­prednisolone in Nonintubated Patients with Severe COVID-19 Pneumonia." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3790.
Повний текст джерела